Page 4 - Microcap Daily News Today

Meta Materials (NASDAQ: MMAT) has been a hot topic as of late, with investors all over the web talking about a potential resurgence. If we rewind to late 2020 and glance at their stock chart, we witness an impressive surge from around $0.54 to a peak of $13.52, an astonishing 2400% gain within' the span

Tempest Therapeutics (NASDAQ: TPST) experienced a remarkable market upswing of over 2,800%, showcasing one of the most substantial gains this year for a once tiny biotech company trading on the Nasdaq. The surge is undeniably tied to their recent press release. However, decoding the significance of this update can be puzzling for everyday investors who

Shares of Splash Beverage Group (NYSE: SBEV), experienced a substantial surge of approximately 100% in the early part of this year. The company houses a portfolio of beverage brands, but the upward momentum has lacked consistency. Regardless, some investors perceive its growth potential to rival industry giants like Celsius Holdings (NASDAQ: CELH) and Monster Beverage

Shares of Clean Vision Corporation (OTC: CLNV) have seen an uptrend of 180% since September 18th, 2023. This emerging developer of sustainable clean technology hasn't had a press release since September 7th, 2023. The company's seen substantial growth without targeted press releases to update investors. However if you look closer, a deeper narrative emerges. We

Orchard Therapeutics (NASDAQ: ORTX) experienced a remarkable 97% surge in its shares following a major announcement on October 5th, 2023. The renowned global gene therapy leader, Orchard, has been successfully acquired by Kyowa Kirin (OTC: KYKOF), solidifying its position as a fully owned subsidiary. The Agreement: The agreement outlines that Kyowa plans to buy all

On October 2nd, 2023, IceCure Medical (NASDAQ: ICCM) shares surged by over 50% following exciting news presented at a major medical event, the European Society of Breast Imaging. Their cutting-edge ProSense® System, designed for minimally invasive cryoablation, is marketed and sold worldwide for its cleared indications in the U.S., Europe, and China. More recently they

Organogenesis Holdings (NASDAQ: ORGO), a top regenerative medicine company dedicated to advanced wound care, surgical, and sports medicine solutions, gains over 30% during intraday trading and after hours combined after their latest release. According to the release, three Medicare Administrative Contractors (MACs) decided to withdraw certain coverage rules that were meant to start on October

On September 25, 2023, Vaccitech (NASDAQ: VACC) experienced a jaw-dropping 90% surge in its stock price in just one day of trading. Now, this kind of jump usually happens when a company drops a major announcement or puts out a significant SEC filing. But, surprise, surprise—there was nothing of that sort this time .So naturally

Femasys Inc. (NASDAQ: FEMY) hit a massive milestone and saw shares soar by a whopping 346%. The reason? The United States Food and Drug Administration (FDA) has given the thumbs up for the commercialization of FemaSeed, a game-changing option for artificial insemination aiming to boost the natural fertilization process. FemaSeed: It's a breakthrough treatment for

MSP Recovery (NASDAQ: LIFW) has been on quite the rollercoaster ride, defying gravity with over 400% gain since September 14th, 2023 with over 240% of that gain happening this week alone. However, the exact reasons behind this meteoric rise remain elusive. Typically, when a company drops major news, you'd expect an instant stock reaction. But